Subcellular myocardial effects of verapamil and D600: comparison with propranolol.
D000200:Action Potentials / Q000187:drug effects; D000067956:Adenylyl Cyclase Inhibitors; D000262:Adenylyl Cyclases / Q000032:analysis; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000037:antagonists & inhibitors / Q000378:metabolism; D002132:Calcium Radioisotopes; D002462:Cell Membrane / Q000201:enzymology; D000242:Cyclic AMP / Q000032:analysis / Q000378:metabolism; D004837:Epinephrine / Q000494:pharmacology; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D009206:Myocardium / Q000201:enzymology / Q000648:ultrastructure*; D011433:Propranolol / Q000494:pharmacology*; D012519:Sarcoplasmic Reticulum / Q000187:drug effects / Q000378:metabolism; D013056:Spectrophotometry, Ultraviolet; D013997:Time Factors; D014316:Tritium; D014700:Verapamil / Q000031:analogs & derivatives* / Q000494:pharmacology*
D000067956:Adenylyl Cyclase Inhibitors; D000319:Adrenergic beta-Antagonists; D002132:Calcium Radioisotopes; D014316:Tritium; D011433:Propranolol; D014700:Verapamil; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D007545:Isoproterenol; D002118:Calcium; D004837:Epinephrine